IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor
Abstract
No abstract availableKeywords
Funding Information
- American Asthma Foundation Scholar Award (13-0066)
- National Institutes of Health (NIH) awards (R01AR068436, R33CA206937)
- Department of Energy Office of Science by Argonne National Laboratory (DE-AC02-06CH11357)
- Cornell High Energy Synchrotron Source
- National Science Foundation award (DMR-0936384)
- NIH (GM-103485)
- University of Maryland School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014)
This publication has 60 references indexed in Scilit:
- Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 bindingProceedings of the National Academy of Sciences, 2012
- Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkinesNature Chemical Biology, 2012
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin GProceedings of the National Academy of Sciences, 2012
- Structural Linkage between Ligand Discrimination and Receptor Activation by Type I InterferonsCell, 2011
- The Utility of Hydrogen/Deuterium Exchange Mass Spectrometry in Biopharmaceutical Comparability StudiesJournal of Pharmaceutical Sciences, 2011
- Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors—Insight into Heterotrimeric IL-1 Signaling ComplexesStructure, 2009
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1Proceedings of the National Academy of Sciences, 2009
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007